DIFFUSION NGF & BIOLOGICAL RESPONSE FROM BASAL FOREBRAIN CHOLINERGIC NEURONS
DIFFUSION NGF & BIOLOGICAL RESPONSE FROM BASAL FOREBRAIN CHOLINERGIC NEURONS
批准号:
6116643
负责人:
MARK H. TUSZYNSKI
金额:
$5.21万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2000-04-30
关键词:
中文摘要
神经生长因子对基底前脑表型的调节意义
胆碱能神经元(BFCN)并能促进BFCN存活
损伤或与年龄相关的退化。因此,NGF可能在
治疗阿尔茨海默病神经元丢失的胆碱能成分
疾病。然而,脑室内输注NGF会导致
来自非目标系统的重大不利影响;因此,当地和
实质内向BFCNs输送NGF是必要的。目标为
确定实质内(IP)注射NGF是否扩散到
距离足以从广泛的
BFCNs在灵长类、成年恒河猴(n=4)中的数量介于
7岁和19岁的儿童连续输注NGF[1.0
Mg/mlx12ml/天]进入纹状体或核内3天
基底大细胞(NBM)。对脑部切片进行免疫标记
神经生长因子[Mufson等人,1994],脑脊液和血清样本检测
NGF蛋白含量采用双点酶联免疫吸附试验。结果NGF提供IP
在6-10毫米的球形分布中扩散,并访问
大多数NBM神经元。仅检测到微量的NGF
腹腔注射后给予脑脊液。因此,脑实质内的未来方向
NGF输注广泛扩散,仅提高脑脊液水平
稍微有点。这些结果进一步支持了将IP
输液可以提供一种替代ICV输液的方法
营养因子长期进入中枢神经系统。关键词老化,
阿尔茨海默氏症,神经营养因子资助NIH Grant AG10435
英文摘要
Significance NGF regulates the phenotype of basal forebrain
cholinergic neurons (BFCN) and can promote BFCN survival following
injury or age-related degeneration. NGF may therefore be useful in
treating the cholinergic component of neuronal loss in Alzheimer's
disease. However, intracerebroventricular infusions of NGF cause
substantial adverse effects from non-targeted systems; thus, local and
intraparenchymal delivery of NGF to BFCNs is necessary. Objectives To
determine whether intraparenchymal (IP) infusions of NGF diffuse for
distances sufficient to elicit neurotrophic effects from the extensive
population of BFCNs in the primate, adult rhesus monkeys (n=4) between
the ages of 7 and 19 years received continuous infusions of NGF [1.0
mg/ml x 12 ml/day] for 3 days into either the striatum or nucleus
basalis magnocellularis (NBM). Brain sections were immunolabeled for
NGF [Mufson et al., 1994], and CSF and serum samples were assayed for
NGF protein content using a two-site ELISA. Results NGF delivered IP
diffused in a spherical distribution over 6-10 mm and accessed a
majority of NBM neurons. Only slight amounts of NGF were detected in
the CSF after IP. Future Directions Thus, intraparenchymal brain
infusions of NGF diffuse extensively while raising CSF levels only
slightly. These results further support the concept that direct IP
infusions may provide an alternative to ICV infusions for delivering
trophic factors chronically into the CNS. KEY WORDS aging,
Alzheimer's, neurotrophic factor FUNDING NIH Grant AG10435
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing human neural progenitor cells (hNPCs) to FDA IND approval
-
批准号:10642228
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome - Supplement
-
批准号:10876189
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2023
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10663796
-
项目类别:
-
资助金额:$112.85万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10185291
-
项目类别:
-
资助金额:$120.15万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10402369
-
项目类别:
-
资助金额:$114.19万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
ShEEP request for a Zeiss LSM 880 with Airyscan confocal system
-
批准号:9573958
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome
-
批准号:10386916
-
项目类别:
-
资助金额:$63.63万
-
财政年份:2017
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome
-
批准号:10211059
-
项目类别:
-
资助金额:$66.34万
-
财政年份:2017
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome
-
批准号:10650134
-
项目类别:
-
资助金额:$63.09万
-
财政年份:2017
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:10538563
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:9822285
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:10322642
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:10267465
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:9468259
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:8804160
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8927970
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8868875
-
项目类别:
-
资助金额:$86.19万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8579707
-
项目类别:
-
资助金额:$119.42万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:9318419
-
项目类别:
-
资助金额:$59.56万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:9114022
-
项目类别:
-
资助金额:$92.55万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
海外基金